KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Short-term Investments (2017 - 2025)

Historic Short-term Investments for Emergent BioSolutions (EBS) over the last 11 years, with Q3 2025 value amounting to $3.7 million.

  • Emergent BioSolutions' Short-term Investments fell 4307.69% to $3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year decrease of 4307.69%. This contributed to the annual value of $6.1 million for FY2024, which is N/A changed from last year.
  • Per Emergent BioSolutions' latest filing, its Short-term Investments stood at $3.7 million for Q3 2025, which was down 4307.69% from $3.7 million recorded in Q2 2025.
  • Over the past 5 years, Emergent BioSolutions' Short-term Investments peaked at $6.5 million during Q3 2024, and registered a low of $100000.0 during Q3 2022.
  • Moreover, its 4-year median value for Short-term Investments was $350000.0 (2021), whereas its average is $1.9 million.
  • Its Short-term Investments has fluctuated over the past 5 years, first tumbled by 5000.0% in 2022, then skyrocketed by 64000.0% in 2025.
  • Quarter analysis of 4 years shows Emergent BioSolutions' Short-term Investments stood at $200000.0 in 2021, then crashed by 50.0% to $100000.0 in 2022, then soared by 6000.0% to $6.1 million in 2024, then plummeted by 39.34% to $3.7 million in 2025.
  • Its Short-term Investments stands at $3.7 million for Q3 2025, versus $3.7 million for Q2 2025 and $3.7 million for Q1 2025.